These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32566139)

  • 1. The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
    Guerin PJ; Singh-Phulgenda S; Strub-Wourgaft N
    F1000Res; 2020; 9():225. PubMed ID: 32566139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controls to Minimize Disruption of the Pharmaceutical Supply Chain During the COVID-19 Pandemic.
    Cundell T; Guilfoyle D; Kreil TR; Sawant A
    PDA J Pharm Sci Technol; 2020; 74(4):468-494. PubMed ID: 32467176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allocation of pharmaceutical resources in maternal and child healthcare institutions during the COVID-19 pandemic.
    Cai J; Chen W; Yang X; Yang X; Li G
    Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):41-47. PubMed ID: 32965355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Supply Chains: COVID-19 Challenges and Pressing Actions.
    Mirchandani P
    Ann Intern Med; 2020 Aug; 173(4):300-301. PubMed ID: 32369540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on the global supply chain of antiretroviral drugs: a rapid survey of Indian manufacturers.
    Rewari BB; Mangadan-Konath N; Sharma M
    WHO South East Asia J Public Health; 2020 Sep; 9(2):126-133. PubMed ID: 32978345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. China's Coronavirus-Induced Paralysis Threatens U.S. Drug Supply Chain.
    Miller HI; Cohrssen JJ
    Mo Med; 2020; 117(2):86-88. PubMed ID: 32308220
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of end-of-life drugs by family caregivers during covid-19 pandemic.
    Bowers B; Pollock K; Barclay S
    BMJ; 2020 Apr; 369():m1615. PubMed ID: 32332027
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of COVID-19 on Indian Pharmaceutical Industry and Way Forward.
    Jadhav NV; Singh N; Targhotra M; Chauhan MK
    Infect Disord Drug Targets; 2021; 21(4):484-494. PubMed ID: 32888279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why the COVID-19 pandemic should be a call for action to advance equitable access to medicines.
    Kohler JC; Mackey TK
    BMC Med; 2020 Jun; 18(1):193. PubMed ID: 32586387
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensifying vaccine production.
    Bull World Health Organ; 2020 May; 98(5):302-303. PubMed ID: 32514194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.
    Gupta N; Potdar V; Praharaj I; Giri S; Sapkal G; Yadav P; Choudhary ML; Dar L; Sugunan AP; Kaur H; Munivenkatappa A; Shastri J; Kaveri K; Dutta S; Malhotra B; Jain A; Nagamani K; Shantala GB; Raut S; Vegad MM; Sharma A; Choudhary A; Brijwal M; Balakrishnan A; Manjunatha J; Pathak M; Srinivasan S; Banu H; Sharma H; Jain P; Sunita P; Ambica R; Fageria B; Patel D; Rajbongshi G; Vijay N; Narayan J; Aggarwal N; Nagar A; Gangakhedkar RR; Abraham P
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):216-225. PubMed ID: 32242875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospital pharmacy in COVID-19.
    Claramunt-García R; Muñoz-Cid CL; Sierra-Torres MI; Merino-Almazán M
    Farm Hosp; 2020 Jun; 44(7):74. PubMed ID: 32533677
    [No Abstract]   [Full Text] [Related]  

  • 13. Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study.
    Badnjević A; Pokvić LG; Džemić Z; Bečić F
    Biomed Eng Online; 2020 Oct; 19(1):75. PubMed ID: 33008462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic: Lessons learned and future directions.
    Khanna RC; Cicinelli MV; Gilbert SS; Honavar SG; Murthy GSV
    Indian J Ophthalmol; 2020 May; 68(5):703-710. PubMed ID: 32317432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercial influence and covid-19.
    Moynihan R; Macdonald H; Bero L; Godlee F
    BMJ; 2020 Jun; 369():m2456. PubMed ID: 32580930
    [No Abstract]   [Full Text] [Related]  

  • 16. Are there positive lessons for Italy's NHS resulting from the Covid-19 pandemic?
    Baldino G; Argo A; Stassi C; Zerbo S; Ventura Spagnolo E
    Med Leg J; 2020 Jul; 88(2):84-86. PubMed ID: 32419599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to COVID-19 pandemic: Why a strong health system is required.
    Dikid T; Chaudhary S; Goel K; Padda P; Sahu R; Kumar T; Jain SK; Singh SK; Narain JP
    Indian J Med Res; 2020 Feb & Mar; 151(2 & 3):140-145. PubMed ID: 32317411
    [No Abstract]   [Full Text] [Related]  

  • 18. "Pandemonium of the pandemic": Impact of COVID-19 in India, focus on mental health.
    Banerjee D; Bhattacharya P
    Psychol Trauma; 2020 Sep; 12(6):588-592. PubMed ID: 32744842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.
    Avorn J; Kesselheim AS
    N Engl J Med; 2020 Oct; 383(18):1706-1708. PubMed ID: 32931162
    [No Abstract]   [Full Text] [Related]  

  • 20. Will COVID-19 pandemic-associated lockdown increase myopia in Indian children?
    Sumitha M; Sanjay S; Kemmanu V; Bhanumathi MR; Shetty R
    Indian J Ophthalmol; 2020 Jul; 68(7):1496. PubMed ID: 32587217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.